BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2496044)

  • 1. Immunostimulatory activity of 1-O-acylated muramyl dipeptides, with or without a 6-O-phosphoryl group, in aqueous form.
    Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Nagamine T; Aizawa C; Mizunoe K; Kiso M; Hasegawa A; Nomoto K
    Int J Immunopharmacol; 1989; 11(1):35-43. PubMed ID: 2496044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.
    Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Watanabe M; Aizawa C; Kiso M; Hasegawa A; Nomoto K
    Infect Immun; 1989 Jun; 57(6):1839-44. PubMed ID: 2722242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methyl esterification of isoglutamine residue in 6-O-acylated muramyl dipeptides on expression of immunopharmacological activities.
    Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Kiso M; Hasegawa A; Nomoto K
    Int J Immunopharmacol; 1991; 13(5):573-7. PubMed ID: 1783471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide.
    Saiki I; Tokushima Y; Nishimura K; Yamamura Y; Azuma I
    Infect Immun; 1983 May; 40(2):622-8. PubMed ID: 6840857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
    Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
    Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
    Tsujimoto M; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacological activities of chemically synthesized lipid A-subunit analogue GLA-27 combined with muramyl dipeptide via spacers of different carbon chain length.
    Ikeda S; Kumazawa Y; Sai K; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
    Int J Immunopharmacol; 1988; 10(4):339-46. PubMed ID: 2459075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
    Durette PL; Dorn CP; Friedman A; Schlabach A
    J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.
    Bloksma N; Hofhuis FM; Willers JM
    Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.
    Matsumoto K; Ogawa H; Kusama T; Nagase O; Sawaki N; Inage M; Kusumoto S; Shiba T; Azuma I
    Infect Immun; 1981 May; 32(2):748-58. PubMed ID: 7019079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
    Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
    Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
    Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
    Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
    Fraser-Smith EB; Matthews TR
    Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
    Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
    Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
    Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
    Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.